Opsens Inc T.OPS

Healthcare Medical Devices

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.

TSX:OPS - Post by User

Opsens Inc

<< Previous

Bullboard Posts

Next >>

Post by bossuon Oct 27, 2022 9:11am

179 Views

Post# 35052555

Projected revenue in 2023 = $ 44 M

According to
Raymond James analyst Rahul Sarugaser
Probable 2022 revenue of $ 35 M and 2023 projected revenue of $ 44 M or 25 % increase and
EBITDA loss of $9 million.or about the same as this year !
In my ming a higher top line revenue should deliver a better EBITDA
And what about the $ 100 M in 3 years ?
Let's see what Mr Laflamme will announce in the year end 2022 Financial Report !
However I like the $ 6,00 share price projection !

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly